You just read:

BioLineRx Announces Initiation of Immuno-Oncology Phase 2 Study to Investigate Combination of BL-8040 and KEYTRUDA® for Pancreatic Cancer

News provided by

BioLineRx Ltd.

Jan 17, 2017, 07:00 ET